- Home
- Publications
- Publication Search
- Publication Details
Title
Complement Inhibitor Therapy for Myasthenia Gravis
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-06-03
DOI
10.3389/fimmu.2020.00917
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis
- (2020) James F. Howard et al. JAMA Neurology
- Eculizumab improves fatigue in refractory generalized myasthenia gravis
- (2019) Henning Andersen et al. QUALITY OF LIFE RESEARCH
- Long‐term safety and efficacy of eculizumab in generalized myasthenia gravis
- (2019) Srikanth Muppidi et al. MUSCLE & NERVE
- Investigational RNAi Therapeutic Targeting C5 Is Efficacious in Pre-clinical Models of Myasthenia Gravis
- (2019) Linda L. Kusner et al. Molecular Therapy-Methods & Clinical Development
- Myasthenia Gravis: Pathogenic Effects of Autoantibodies on Neuromuscular Architecture
- (2019) Koneczny et al. Cells
- Role of complement and potential of complement inhibitors in myasthenia gravis and neuromyelitis optica spectrum disorders: a brief review
- (2019) Jayne L. Chamberlain et al. JOURNAL OF NEUROLOGY
- SHP2 inhibitor protects AChRs from effects of myasthenia gravis MuSK antibody
- (2019) Saif Huda et al. Neurology-Neuroimmunology & Neuroinflammation
- Serological and experimental studies in different forms of myasthenia gravis
- (2018) Angela Vincent et al. Annals of the New York Academy of Sciences
- Rationale for the clinical guidelines for myasthenia gravis in Japan
- (2018) Hiroyuki Murai et al. Annals of the New York Academy of Sciences
- Acetylcholine receptor antibody-mediated animal models of myasthenia gravis and the role of complement
- (2018) Linda L. Kusner et al. Annals of the New York Academy of Sciences
- Burden of illness in patients with treatment refractory myasthenia gravis
- (2018) Nicole M. Engel-Nitz et al. MUSCLE & NERVE
- Pathogenic Mechanisms and Clinical Correlations in Autoimmune Myasthenic Syndromes
- (2018) Hakan Cetin et al. SEMINARS IN NEUROLOGY
- Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study
- (2017) James F Howard et al. LANCET NEUROLOGY
- Intracellular complement − the complosome − in immune cell regulation
- (2017) Giuseppina Arbore et al. MOLECULAR IMMUNOLOGY
- Myasthenia Gravis
- (2017) NEW ENGLAND JOURNAL OF MEDICINE
- International consensus guidance for management of myasthenia gravis
- (2016) Donald B. Sanders et al. NEUROLOGY
- Guidelines for pre-clinical assessment of the acetylcholine receptor-specific passive transfer myasthenia gravis model—Recommendations for methods and experimental designs
- (2015) Linda L. Kusner et al. EXPERIMENTAL NEUROLOGY
- Genetic Variants in C5 and Poor Response to Eculizumab
- (2014) Jun-ichi Nishimura et al. NEW ENGLAND JOURNAL OF MEDICINE
- Complement C2 siRNA mediated therapy of myasthenia gravis in mice
- (2013) Ruksana Huda et al. JOURNAL OF AUTOIMMUNITY
- A randomized, double-blind, placebo-controlled phase II study of eculizumab in patients with refractory generalized myasthenia gravis
- (2013) James F. Howard et al. MUSCLE & NERVE
- Targeting therapy to the neuromuscular junction: Proof of concept
- (2013) Linda L. Kusner et al. MUSCLE & NERVE
- Cell surface complement regulators moderate experimental myasthenia gravis pathology
- (2012) Linda L. Kusner et al. MUSCLE & NERVE
- Protective effect of scFv-DAF fusion protein on the complement attack to acetylcholine receptor: A possible option for treatment of myasthenia gravis
- (2011) Chen Song et al. MUSCLE & NERVE
- Novel complement inhibitor limits severity of experimentally myasthenia gravis
- (2009) Jindrich Soltys et al. ANNALS OF NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started